Get started

Bioconanalysis

BIOCON : A Cup and Handle BreakoutIn this falling market BIOCON is showing a cup and handle Breakout with good amount of volume. Upside potential is 45% (approx.) ... CMP : 388 TG1 : 485 (High) TG2 : 570 SL : 329 TSL : Below 9 EMA Stock's selection based on 5 Point Analysis: 1: Idea : Breakout. 2: Support : Volume, Delivery . 3: Technical : 21/55/200-EMA, Super trend up, RS>0 RSI. 4: Fundamental : PE, PAT, Industry & peer PE and sector performance. 5: Timing : Entry Timing on Daily chart. Disclaimer : It is my personal view as a trader and for educational purpose only. Equity market involves risk . Please consult your financial adviser before taking any decision.
NSE:BIOCONLong
by SthitaprajnaYogi
3
Biocon Higher Lows and Key Levels Broken.NSE:BIOCON today made higher Lows and Broke Out Key Levels, with RSI and MACD showing a Bullish Momentum, a Swing up to 400 Looks Good and Postionally 450. 📌Thank you for exploring my idea! I hope you found it valuable. 🙏FLLOW for more 👍BOOST if useful ✍️COMMENT Below your views. Meanwhile, check out my other stock ideas below until this trade is activated. I would love your feedback. Disclaimer: This analysis is intended solely for informational and educational purposes and should not be interpreted as financial advice. It is advisable to consult a qualified financial advisor or conduct thorough research before making investment decisions.
NSE:BIOCONLong
by Karanshah137
Putting Price Action Altogether | BIOCON LIMITED ⚡️ Investing opportunity: Price Action Analysis Alert !!!⚡️ ⚠️Education Purpose only!!!! 1️⃣Biocon Limited Overview 📍Founded: 1978 by Kiran Mazumdar-Shaw 📍Headquarters: Bengaluru, Karnataka, India 📍Markets: Over 120 countries, including the United States and Europe 2️⃣Key Business Divisions 👉Generics: Produces generic APIs for global markets. 👉Biosimilars: Focuses on biosimilar insulins and monoclonal antibodies. 👉Research Services: Contract research and development via subsidiary Syngene International. 👉Novel Biologics: Develops innovative therapies for diseases like cancer, diabetes, and autoimmune disorders. 3️⃣Financial Performance ✅Net Loss: ₹160 million ✅Revenue: ₹35.9 billion, up 3.7% YoY. ✅Biosimilars Revenue: Increased by 11% (U.S., Europe). ✅Generics Revenue: Declined by 7.7% 4️⃣Technical Reasons to trade or Strategy applied :- ⭕️50 Day Moving averages shows strong Bullishness in Long-Term ⭕️Head&Shoulder Pattern Breakout ⭕️Breakout with strong Volume ⭕️Channel Pattern Formation ⭕️Upward Trendline for Resistance ⭕️Higher-Lows Formation before Breakout ⭕️Trendline Breakout too 5️⃣Key Takeaways ⚠️Strengths: Strong global presence and diverse biopharmaceutical portfolio. ⚠️Challenges: Recent profitability concerns due to pricing pressures and tax adjustments. ⚠️Growth Potential: Biosimilars and novel biologics present significant long-term opportunities. ⚠️Investor Consideration: Combine fundamental and technical analyses to assess investment decisions. ✅Check out my Trading View profile to see how we analyze charts and execute trades. 🙋‍♀️🙋‍♂️If you have any questions about this stock, feel free to reach out to me. 📍📌Thank you for exploring our idea! We hope you found it valuable. 🙏FLLOW for more ! 👍LIKE if useful ! ✍️COMMENT Below your view
NSE:BIOCON
by ReviveTraders
BIOCON - Swing/Positional Trading opportunity This is a weekly chart to analyze the bigger picture in the stock One can clearly see that stock is in Stage-2 uptrend with both Key MAs sloping up Price bouncing from Key MAs (especially 40 week MA) Volume activity is also favorable as of now Relative strength of the stock is also high as compared to CNX500 on 52 week basis Instead of just jumping on to the stock the very next day, I would prefer to wait for a low risk entry so that I can have bigger position with lower SL size. This is not a recommendation. Pls do your own study before putting any money in any stock. Share this with your friends if you find this useful. For more learning stuff related to chart analysis, pls check out my other ideas (some of them are linked below) You can always reach out to me anytime for any query or feedback. Keep learning
NSE:BIOCONLong
by TradewithAditya
BIOCON LTD READY FOR A UPSWING (SWING TRADING SETUP)Since last weeks we have seen pharma sector is outperforming and this performance may continue. As per price action biocon ltd Has created a Cup but handle is still remaining. If this stock creates a handle which is highly possible then price can be bullish for few trading sessions. Price should sustain above Trend line then it will be good. For more confirmation wait for the price to come at resistance level and look for RSI above 70. If fails and test previous support then this Overview will be considered as NULL.(Conditions not fulfilled)
NSE:BIOCONLong
by jain_abhishek
Biocon Indicates Flag Pattern Breakout and Positive ResultsDetails: Asset: Biocon Limited (BIOCON) Breakout Level: Above 320 Expected Target: 340 and beyond Stop Loss: Below breakout level or as per risk tolerance Timeframe: Short to medium-term Rationale: Biocon Limited (BIOCON) is displaying a flag pattern breakout potential alongside positive results. A breakout above the 320 level could signify a bullish momentum shift, especially supported by positive earnings results. Market Analysis: Technical Breakout: The breakout above 320 indicates a potential flag pattern breakout, suggesting increased buying interest and potential for further upside momentum. Positive Results: Strong earnings results can act as a catalyst for bullish sentiment and further support the breakout scenario. Expected Target: The initial target for BIOCON is set at 340 and beyond, considering the potential momentum from the breakout and positive results. Risk Management: Implementing a stop loss strategy below the breakout level is crucial to manage risk in case of unexpected price reversals. Timeframe: The projected move for BIOCON is based on a short to medium-term outlook, considering both technical breakout and fundamental catalysts. Risk-Reward Ratio: Consider individual risk tolerance and adjust position size accordingly to maintain a favorable risk-reward ratio. As with any investment opportunity, conduct thorough analysis and consider factors such as market trends, company fundamentals, and risk ma
NSE:BIOCONLong
by CyborgTradingHub
Biocon : Bottomed out Stock#Biocon #Momentumstock #Swingtrade #BreakoutCandidate BIOCON : 200 EMA Breakout Soon >> Momentum Stock >> Bottomed-out Stock >> Good Strength & volumes in stock >> Low Risk High Reward Trade Swing Traders can lock 10% profit & keep trailing Please give a Boost or comment if u r Liking the analysis & Learning from it. Keep showing ur Love by following Disclaimer : This is not a Trade Recommendations & Charts/ stocks Mentioned are for Learning/Educational Purpose. Do your Own Analysis before Taking positions.
NSE:BIOCONLong
by moneyfesttrading
4